Acute haemorrhagic ulcerative colitis

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
B Haematology (ATC B) 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Supportive / diluent 1 substance
Monoclonal antibody (immune, humanized) 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Alvotech Swiss AG Commercial
    SODIUM CHLORIDE; VEDOLIZUMAB
    2023-507705-34-00 11 countries 2025 n=462
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Alvotech Swiss AG Commercial 1 Phase III 0
New trials by year
2025
1
← All indication landscapes